| Tag | Content |
|---|
EnhancerAtlas ID | HS055-08348 |
Organism | Homo sapiens |
Tissue/cell | FT33 |
Coordinate | chr8:101911880-101913960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Esrra | MA0592.2 | chr8:101913941-101913952 | ATGACCTTGAG | - | 6.02 | | Esrrg | MA0643.1 | chr8:101913941-101913951 | ATGACCTTGA | - | 6.02 | | SOX10 | MA0442.2 | chr8:101912106-101912117 | TGCTTTGTTTT | - | 6.02 | | ZNF263 | MA0528.1 | chr8:101912886-101912907 | GGGGGATGGGGAAGAAAGGAA | + | 6.03 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10716 | chr8:101911992-101915431 | CD19_Primary | | SE_11102 | chr8:101911654-101916492 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr8 | 101912406 | 101912993 | | chr8 | 101911897 | 101913305 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I100899 | chr8 | 101911621 | 101915177 |
|
Enhancer Sequence | CACTCCCTGG CCACTTGTAG AGTTAATTCA AATTCTAGAG AGAAACAGCG CTCGGATTGA 60
TCCAGCTCAG TTCTTCAATC CAGGCCACCC AGTCACTAGT CAGCCAATGC GCATTGCCGT 120
CTTTGGCTCA GGCGACCGTT CCCTGTCAGG CCAGCAGAGT GAGAGAGTCT AACGGGGTCC 180
CTCTTCCAAG GGCGCGGGCC AGGCGAGTTA TAGAGGAAGG TTGTTTTGCT TTGTTTTTGT 240
TTTCTAATCT GGTGGAGAAG AGACAAAAGG AGAAATGGGA AGGAAAACAG GGGCCTCTCT 300
GGCAAGCAAG TCGCAGGTGT GAGGCCCAGA AGCCTGAACA GTAATAGCGC ATTGGAGGCA 360
CCTGAGAGGC TCAGTGACGG CGTCTTCACC CAGAGGCACT ATTCAAATAG CAACTCGTGT 420
GGCATGGGCA CCGGCCACTC AGAACGGGCA GCGGCAGGGA CAGCGGGATG GCAGGAAGTC 480
CTGACCATCC GACCTGCCCT GATGTGTCAT GATGTTTCCT TGTGCATGTG CATTTTTCAT 540
GAGGCGTGTG GCCATCTCTT ATCAGCCTTT GTGACCTCAT TTCCTCCTTT TTCAAATGAG 600
CACTTCCAGG AGCCCAGGGG AAGGGTTGGC TTTGGAGGGT TTGGCCAGGG TTGGGGGGCA 660
CCTCCAGGCC CCTGCGGAGT GGACAGCGCA GTTGTGCCTT CCAGCTGCTG CTTAGGTCTT 720
AGGGAAACTC ATCTGCTCAA GGGGGCTTAG GGAATCTGAT TTGCTTTTCC TTTTCTCAGC 780
CTTTCTGAGC ATAGGGAGAA GGAGGAAGCA GTTCGAATCC CATTGCGGGC TGCAGAGAGT 840
TCTGGATGAG TAAGCACCAA AAACGTGGGA AGTTTCTGAA AAGGGTTTCT CAGCCAGCAG 900
TGCTTTCACC CCTTGCTGGG CGAGTCGCTG CCGTGCAGTG CAGATGACTC ATCTGGGTAA 960
CTCCCTTGAC AGAAGGAGCC AGCCAAGCTG CAGCAAATGT GCGTTGGGGG GATGGGGAAG 1020
AAAGGAATGA ACACAGAGCA TTCCCTGTCA CCAGACGCTA TGCTAGACAC TATGTGTATC 1080
ATCTTATTAA ATGATCCCAA ATACCCTGTG ACGATTCCAT CCCAGATACT CTGGCCCCAC 1140
CGCACACCTT GGGATCCACT ACATGAACAC TTCCTTTCCT GACGTCCCCA GGGCCCACCT 1200
ATTTCACATG AAGCTCTGGA TACTGTCAGA AAAAAACATC CAACACCTGG AGATAAGGCC 1260
AAGAAGGTGG CCGGCACATC CTTTCAATAT CGTAGGTGGT AACAGGCCAC CTTTATGAAT 1320
CTCGCAGTCT AATACAATAG CCACTAGCCA AGTGTGGTTA CAGAGCTCCT GACATACGCC 1380
AGTGTGAATT GAGATGTGCT GTAAGTGTAT GATCTACACT GGGTTTCAAA GACTTAGTAT 1440
GACAAAAATT ATAATGTACC TTATTAACAT TTTTAATGTT GAGTTCATGT TGAAATAGTA 1500
TTTTTGATAT ATTGGGTTAA AGAAAACATC ATTTAAATTA ATTTCAGGTT AGGTGAGGTG 1560
GCTCATGCCT GTAATCCTAG CACTTTGGGA GGCCAAGGCA GGAGGATTGC TTGAGCCCAG 1620
GAGTTTGAGA CCAGCCTTGG CAACATAGAG AGACCCTGTC TCTACAAACA AAAAACAAAA 1680
CAAATAGCCA GGTGTGGTGG TGGAGATATT TTGCATTCTT TTTTTATAGT AAGTCTTCAA 1740
AATCTAGCAC ATCTCAGTTT GGACCAGCCA CATTTCAACT TCTTAAGAGT CACATACAGT 1800
GAGTAGCTAC CATATTGAGC AGTGCAGGTT TCGATCCTAT GCTTAGAAGG ATCATGACCA 1860
ACAAATAAAG GCAGTTCAAG TTCTCTAGTG TTCCAGTGTG AGCTGGAAGG CAGTTGTCTC 1920
TACAAAGGGA TCTTTTTCTA TCCAAGGCAA CCACAGGGCT GGGGATGGTA GGTGTGGAGC 1980
TGTACCTTAA AGCATATGTT AATGCTCTGG AAATCCATGT CTTTCCTTCA GACATTTCCC 2040
TCCTCTCTGT TCATAAGCTA CATGACCTTG AGCAAATCAC 2080
|
